Entreprise · 27/12/20161 min de lecture
Psychopharmacologic Drugs Advisory Committee; Notice of Meeting
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Psychopharmacologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.